LORFAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lorfan, and when can generic versions of Lorfan launch?
Lorfan is a drug marketed by Roche and is included in one NDA.
The generic ingredient in LORFAN is levallorphan tartrate. Additional details are available on the levallorphan tartrate profile page.
Summary for LORFAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 16 |
Formulation / Manufacturing: | see details |
DailyMed Link: | LORFAN at DailyMed |
US Patents and Regulatory Information for LORFAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Roche | LORFAN | levallorphan tartrate | INJECTABLE;INJECTION | 010423-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |